Evolus Inc. (EOLS)
Bid | 4.47 |
Market Cap | 402.79M |
Revenue (ttm) | 277.49M |
Net Income (ttm) | -61.99M |
EPS (ttm) | -0.97 |
PE Ratio (ttm) | -6.42 |
Forward PE | 22.36 |
Analyst | Buy |
Dividends | n/a |
Ask | 8.01 |
Volume | 235,433 |
Avg. Volume (20D) | 1,371,082 |
Open | 6.21 |
Previous Close | 6.21 |
Day's Range | 6.18 - 6.29 |
52-Week Range | 5.71 - 17.82 |
Beta | 1.04 |
Ex-Dividend Date | n/a |
About EOLS
undefined
Analyst Forecast
According to 0 analyst ratings, the average rating for EOLS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsAnalysts project revenue of ... Unlock content with Pro Subscription

3 weeks ago · businesswire.com
Evolus Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qu...

2 months ago · businesswire.com
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant in August...

2 months ago · businesswire.com
Evolus to Report Second Quarter Financial Results on August 5, 2025NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will repor...